Essential Partners’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$34.5K Sell
156
-12
-7% -$2.62K 0.02% 735
2026
Q2
$32.7K Buy
168
+156
+1,300% +$32.3K 0.02% 736
2026
Q1
$2.69K Sell
12
-7
-37% -$1.74K ﹤0.01% 1879
2025
Q4
$4.58K Hold
19
– – ﹤0.01% 1461
2025
Q3
$5.2K Buy
19
+4
+27% +$1.09K ﹤0.01% 1411
2025
Q2
$3.87K Buy
+15
New +$3.58K ﹤0.01% 1128

Other funds holding RMD

Essential Partners's RMD Position: Q3 2026 in Review

Essential Partners reduced its ResMed (RMD) stake by 7.1% in Q3 2026, selling an estimated $2.62K and leaving 156 shares worth $34.5K. The position accounts for 0.02% of the portfolio, ranked #735.

Essential Partners first reported a position in RMD in Q2 2025 and has held it in 6 quarters since. 167 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Essential Partners held 156 shares of ResMed worth $34.5K as of Q3 2026.
  • Essential Partners sold 12 ResMed shares in Q3 2026, an estimated $2.62K.
  • ResMed made up 0.02% of Essential Partners's portfolio in Q3 2026, its #735 holding.
  • Essential Partners first reported a position in ResMed in Q2 2025 and has held it in 6 quarters since.
  • 167 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.